Cargando…

Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation

Background: B-type natriuretic peptide (BNP) is a well-known predictor for prognosis in patients with cardiac and renal diseases. However, there is a lack of studies in patients with advanced hepatic disease, especially patients who underwent liver transplantation (LT). We evaluated whether BNP coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hyun Sik, Woo, AMi, Chae, Min Suk, Hong, Sang Hyun, Park, Chul Soo, Choi, Jong Ho, Jo, Yun Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176164/
https://www.ncbi.nlm.nih.gov/pubmed/34104081
http://dx.doi.org/10.7150/ijms.54202
_version_ 1783703202545270784
author Chung, Hyun Sik
Woo, AMi
Chae, Min Suk
Hong, Sang Hyun
Park, Chul Soo
Choi, Jong Ho
Jo, Yun Sung
author_facet Chung, Hyun Sik
Woo, AMi
Chae, Min Suk
Hong, Sang Hyun
Park, Chul Soo
Choi, Jong Ho
Jo, Yun Sung
author_sort Chung, Hyun Sik
collection PubMed
description Background: B-type natriuretic peptide (BNP) is a well-known predictor for prognosis in patients with cardiac and renal diseases. However, there is a lack of studies in patients with advanced hepatic disease, especially patients who underwent liver transplantation (LT). We evaluated whether BNP could predict the prognosis of patients who underwent LT. Material and Methods: The data from a total of 187 patients who underwent LT were collected retrospectively. The serum levels of BNP were acquired at four time points, the pre-anhepatic (T1), anhepatic (T2), and neohepatic phases (T3), and on postoperative day 1 (T4). The patients were dichotomized into survival and non-survival groups for 1-month mortality after LT. Combined BNP (cBNP) was calculated based on conditional logistic regression analysis of pairwise serum BNP measurements at two time points, T2 and T4. The area under the receiver operating characteristic curve (AUROC) was analyzed to determine the diagnostic accuracy and cut-off value of the predictive models, including cBNP. Results: Fourteen patients (7.5 %) expired within one month after LT. The leading cause of death was sepsis (N = 9, 64.3 %). The MELD and MELD-Na scores had an acceptable predictive ability for 1-month mortality (AUROC = 0.714, and 0.690, respectively). The BNPs at each time point (T1 - T4) showed excellent predictive ability (AUROC = 0.864, 0.962, 0.913, and 0.963, respectively). The cBNP value had an outstanding predictive ability for 1-month mortality after LT (AUROC = 0.976). The optimal cutoff values for cBNP at T2 and T4 were 137 and 187, respectively. Conclusions: The cBNP model showed the improved predictive ability for mortality within 1-month of LT. It could help clinicians stratify mortality risk and be a useful biomarker in patients undergoing LT.
format Online
Article
Text
id pubmed-8176164
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-81761642021-06-07 Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation Chung, Hyun Sik Woo, AMi Chae, Min Suk Hong, Sang Hyun Park, Chul Soo Choi, Jong Ho Jo, Yun Sung Int J Med Sci Research Paper Background: B-type natriuretic peptide (BNP) is a well-known predictor for prognosis in patients with cardiac and renal diseases. However, there is a lack of studies in patients with advanced hepatic disease, especially patients who underwent liver transplantation (LT). We evaluated whether BNP could predict the prognosis of patients who underwent LT. Material and Methods: The data from a total of 187 patients who underwent LT were collected retrospectively. The serum levels of BNP were acquired at four time points, the pre-anhepatic (T1), anhepatic (T2), and neohepatic phases (T3), and on postoperative day 1 (T4). The patients were dichotomized into survival and non-survival groups for 1-month mortality after LT. Combined BNP (cBNP) was calculated based on conditional logistic regression analysis of pairwise serum BNP measurements at two time points, T2 and T4. The area under the receiver operating characteristic curve (AUROC) was analyzed to determine the diagnostic accuracy and cut-off value of the predictive models, including cBNP. Results: Fourteen patients (7.5 %) expired within one month after LT. The leading cause of death was sepsis (N = 9, 64.3 %). The MELD and MELD-Na scores had an acceptable predictive ability for 1-month mortality (AUROC = 0.714, and 0.690, respectively). The BNPs at each time point (T1 - T4) showed excellent predictive ability (AUROC = 0.864, 0.962, 0.913, and 0.963, respectively). The cBNP value had an outstanding predictive ability for 1-month mortality after LT (AUROC = 0.976). The optimal cutoff values for cBNP at T2 and T4 were 137 and 187, respectively. Conclusions: The cBNP model showed the improved predictive ability for mortality within 1-month of LT. It could help clinicians stratify mortality risk and be a useful biomarker in patients undergoing LT. Ivyspring International Publisher 2021-04-23 /pmc/articles/PMC8176164/ /pubmed/34104081 http://dx.doi.org/10.7150/ijms.54202 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Chung, Hyun Sik
Woo, AMi
Chae, Min Suk
Hong, Sang Hyun
Park, Chul Soo
Choi, Jong Ho
Jo, Yun Sung
Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title_full Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title_fullStr Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title_full_unstemmed Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title_short Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation
title_sort combined b-type natriuretic peptide as strong predictor of short-term mortality in patients after liver transplantation
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176164/
https://www.ncbi.nlm.nih.gov/pubmed/34104081
http://dx.doi.org/10.7150/ijms.54202
work_keys_str_mv AT chunghyunsik combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT wooami combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT chaeminsuk combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT hongsanghyun combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT parkchulsoo combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT choijongho combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation
AT joyunsung combinedbtypenatriureticpeptideasstrongpredictorofshorttermmortalityinpatientsafterlivertransplantation